Author:
Sato Yuichi,Breslin David,Kitada Hideyuki,Minagawa Wataru,Nomoto Takashi,Qin Xue-Zhi,Karki Shyam B.
Reference13 articles.
1. Breslin, D., Sato, Y., Karki, S.B., in press. Mechanism of hydrolysis of a novel indolocarbazole topoisomerase I inhibitor. Eur. J. Pharm. Sci.
2. Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy)ethylamino-12,13-dihydro-13-(β-d-gluco pyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]-carbazole-5,7(6H)-dione] against pediatric and adult central nervous system tumor xenografts;Cavazos;Cancer Chemother. Pharmacol.,2001
3. Solubilization of NSC-639829;Jain;Int. J. Pharm.,2001
4. Excipients and their use in injectable products;Nema;PDA J. Pharm. Sci. Technol.,1997
5. Solubilization and preformulation of carbendazim;Ni;Int. J. Pharm.,2002
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献